Biomarin pharmaceutical inc

Major-Pharmaceuticals

BMRN


770 Lindaro Street
San Rafael , CA 94901

Executive/
Director

Price

  • Last Close
  • $ 66.86
    $ +0.33 0.5 %
    Jan 3, 2025
  • 52-Week High/Low
  • $99 - $76.22
  • YTD
  • 1.7%

  • Trading Volume
  • 36,920
  • Market Cap Full
  • $ 12.6B
  • Shares Outstanding
  • 188.4M
    Oct 30, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -21.3% 6% -9.1% 4.3% -5% -13.9% -12.7% -6% -9.4% 1.7%
Q2 -5.7% 3.5% 21.9% -4.8% 4% 10.5% 7.5% -10.9% 1.7% -
Q3 18.9% 2.5% 3.3% -19.4% 8% -7.4% 2.3% 2.1% 8.3% -
Q4 -10.5% -4.9% -13.7% 23.6% 15.3% 14.3% 22.1% 10.7% -1.5% -
J F M A M J J A S O N D
2025 1.7% - - - - - - - - - - -
2024 -8.7% -2% 1.2% 1.5% - - - 8.3% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    16%-21%8%-5%-1%4%1%17%-7%-32%2%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.35 0.09 -0.26 -0.32 0.44 0.09 0.63 0.27
Q2 0.11 0.05 -0.09 -0.21 -0.16 0.07 0.15 0.29
Q3 0.13 0.07 -0.07 0.3 4.01 -0.2 -0.04 0.21
Q4 0.37 0.30 -0.02 0.1 0.24 -0.31 0.01 -
A 1 0.5 -0.4 -0.1 4.5 -0.4 0.8 0.77

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 178.4 179.9 181.8 184 186.5
Jun 176.7 179.1 180.8 182.7 185 187.7
Sep 177.6 179.5 181.3 183.4 185.5 188.2
Dec 178.1 179.6 181.5 183.6 185.8 188.4

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 0.5 0.6 0.8 0.5 0.6
Fixed Asset Turnover 1.3 1.1 1.3 1.1 1.2
Total Asset Turnover 0.3 0.3 0.3 0.4 0.3
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 18.8 4.6 - 1.3 2.6
Equity multiplier 0.3 0.4 0.4 0.5 0.4